Published by Josh White on 14th January 2020
(Sharecast News) - Clinical-stage biotechnology company ValiRx updated the market on its subsidiary joint venture, ValiSeek, and its cancer therapeutic, VAL401 on Tuesday.
URL: http://www.digitallook.com/dl/news/story/30107164/...